Abbott LaboratoriesABTNYSE
Loading
EBITDA Over TimeStrong
Percentile Rank86
3Y CAGR-0.9%
5Y CAGR+5.1%
Year-over-Year Change
Earnings before interest, taxes, depreciation, and amortization
3Y CAGR
-0.9%/yr
vs +14.7%/yr prior
5Y CAGR
+5.1%/yr
Recent deceleration
Acceleration
-15.6pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
2 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $11.55B | +6.6% |
| 2024 | $10.83B | +2.2% |
| 2023 | $10.61B | -10.8% |
| 2022 | $11.89B | -2.2% |
| 2021 | $12.16B | +35.1% |
| 2020 | $9.00B | +13.8% |
| 2019 | $7.91B | +15.0% |
| 2018 | $6.88B | +12.2% |
| 2017 | $6.13B | +99.7% |
| 2016 | $3.07B | - |